AI assistant
STERIS plc — Director's Dealing 2021
Aug 12, 2021
30229_dirs_2021-08-12_32514bce-8ceb-4697-bb0d-163d4109366b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: STERIS plc (STE)
CIK: 0001757898
Period of Report: 2021-08-10
Reporting Person: Breeden Richard C (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-08-10 | Director Stock Option (right to buy) | $217.62 | A | 2027 | Acquired | 2031-08-10 | Ordinary Shares (2027) | Direct |
| 2021-08-10 | Director Stock Option (right to buy) | $217.62 | A | 471 | Acquired | 2031-08-10 | Ordinary Shares (471) | Direct |
| 2021-08-10 | Career Restricted Stock Units | $ | A | 508 | Acquired | Ordinary Shares (508) | Direct | |
| 2021-08-10 | Career Restricted Stock Units | $ | A | 376 | Acquired | Ordinary Shares (376) | Direct |
Footnotes
F1: These nonqualified stock options are fully vested and are exercisable immediately.
F2: These nonqualified stock options were issued to the Reporting Person in lieu of fees of $25,000.
F3: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service.
F4: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service.
F5: These Career Restricted Stock Units were issued to the Reporting Person in lieu of fees of $82,000.